Dolo 650: Popular Painkiller or Silent Liver Threat? Study Sheds Light
Advertisement
Dolo 650, a popular paracetamol brand, is commonly used to treat pain and fever in India. While it's generally safe when taken properly, overuse, especially without medical guidance, can harm the liver and kidneys. Paracetamol overdose is a leading cause of acute liver failure globally, with major medical journals warning that it accounts for more than half of liver failure cases in some countries.
“If you’ve ever had a fever in India, chances are someone handed you a strip of Dolo 650 without blinking,” says Dr. Naveen Polavarapu, a senior gastroenterologist. Its widespread use, particularly during the COVID-19 pandemic, has led to growing concerns among doctors about misuse.
Dr. Polavarapu explains, “Paracetamol is processed by the liver. In normal doses, it’s safe. But when taken in excess, it can lead to liver damage as it depletes an enzyme called glutathione, leading to toxic buildup.”
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.